Latest Insider Transactions at Repligen Corp (RGEN)
This section provides a real-time view of insider transactions for Repligen Corp (RGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REPLIGEN CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REPLIGEN CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
3,322
-1.53%
|
$634,502
$191.79 P/Share
|
|
Feb 29
2024
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
404
+1.45%
|
-
|
|
Feb 29
2024
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
404
+1.71%
|
-
|
|
Feb 29
2024
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
391
+1.32%
|
-
|
|
Feb 29
2024
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
2,504
+1.14%
|
-
|
|
Feb 27
2024
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,691
+27.58%
|
-
|
|
Feb 27
2024
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
19,719
+8.44%
|
-
|
|
Feb 27
2024
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
3,520
+11.5%
|
-
|
|
Feb 27
2024
|
Jason K Garland CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,540
+24.0%
|
-
|
|
Feb 27
2024
|
Olivier Loeillot Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,880
+15.43%
|
-
|
|
Feb 27
2024
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
1,000
-1.13%
|
$193,000
$193.35 P/Share
|
|
Feb 27
2024
|
Karen A Dawes |
BUY
Exercise of conversion of derivative security
|
Direct |
4,626
+4.97%
|
$194,292
$42.07 P/Share
|
|
Feb 23
2024
|
James Bylund Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,373
-23.63%
|
$865,854
$198.08 P/Share
|
|
Feb 23
2024
|
James Bylund Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
940
+4.83%
|
$88,360
$94.33 P/Share
|
|
Nov 14
2023
|
Anthony Hunt |
SELL
Bona fide gift
|
Direct |
1,000
-0.51%
|
-
|
|
Nov 10
2023
|
Christine Gebski |
SELL
Open market or private sale
|
Direct |
3,788
-11.63%
|
$556,836
$147.13 P/Share
|
|
Oct 02
2023
|
Olivier Loeillot Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,906
+50.0%
|
-
|
|
Sep 25
2023
|
Jason K Garland CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,503
+50.0%
|
-
|
|
Aug 29
2023
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
850
-1.0%
|
$145,350
$171.38 P/Share
|
|
Aug 29
2023
|
Karen A Dawes |
BUY
Exercise of conversion of derivative security
|
Direct |
7,392
+8.04%
|
$133,056
$18.12 P/Share
|
|
May 18
2023
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
686
+23.0%
|
-
|
|
May 18
2023
|
Rohin Mhatre |
BUY
Grant, award, or other acquisition
|
Direct |
686
+22.63%
|
-
|
|
May 18
2023
|
Manner Carrie Eglinton |
BUY
Grant, award, or other acquisition
|
Direct |
686
+24.04%
|
-
|
|
May 18
2023
|
Karen A Dawes |
BUY
Grant, award, or other acquisition
|
Direct |
798
+1.02%
|
-
|
|
May 18
2023
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
686
+8.3%
|
-
|
|
May 18
2023
|
Nicolas Barthelemy |
BUY
Grant, award, or other acquisition
|
Direct |
686
+19.87%
|
-
|
|
May 18
2023
|
Konstantin Konstantinov |
BUY
Grant, award, or other acquisition
|
Direct |
686
+35.99%
|
-
|
|
May 16
2023
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
710
-1.86%
|
$109,340
$154.03 P/Share
|
|
May 16
2023
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-1.01%
|
$51,436
$154.03 P/Share
|
|
May 16
2023
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
710
-2.93%
|
$109,340
$154.03 P/Share
|
|
May 08
2023
|
Martin D Madaus |
BUY
Open market or private purchase
|
Direct |
500
+23.69%
|
$78,000
$156.18 P/Share
|
|
May 05
2023
|
Martin D Madaus |
BUY
Open market or private purchase
|
Direct |
500
+31.04%
|
$79,500
$159.19 P/Share
|
|
May 04
2023
|
Martin D Madaus |
BUY
Open market or private purchase
|
Direct |
500
+45.0%
|
$80,500
$161.15 P/Share
|
|
Apr 04
2023
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-1.87%
|
$54,442
$163.45 P/Share
|
|
Mar 24
2023
|
Martin D Madaus |
BUY
Small Acquisition
|
Indirect |
11
+50.0%
|
$2,046
$186.22 P/Share
|
|
Mar 03
2023
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,247
-4.89%
|
$234,436
$188.0 P/Share
|
|
Mar 03
2023
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
3,591
+12.34%
|
-
|
|
Mar 03
2023
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,674
-8.8%
|
$690,712
$188.0 P/Share
|
|
Mar 03
2023
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,795
+17.4%
|
-
|
|
Mar 03
2023
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
126
-0.38%
|
$23,688
$188.0 P/Share
|
|
Mar 03
2023
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
375
+1.12%
|
-
|
|
Mar 03
2023
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
8,244
-4.05%
|
$1,549,872
$188.0 P/Share
|
|
Mar 03
2023
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
18,584
+8.37%
|
-
|
|
Mar 03
2023
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
210
-1.16%
|
$39,480
$188.0 P/Share
|
|
Mar 03
2023
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
625
+3.34%
|
-
|
|
Mar 02
2023
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
3,468
+13.66%
|
-
|
|
Mar 02
2023
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,848
+12.82%
|
-
|
|
Mar 02
2023
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
3,467
+9.6%
|
-
|
|
Mar 02
2023
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
19,393
+9.49%
|
-
|
|
Mar 02
2023
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,348
+32.31%
|
-
|